GPS Wealth Strategies Group’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44
Closed -$3.52K 1369
2024
Q1
$3.52K Hold
44
﹤0.01% 1069
2023
Q4
$4.82K Hold
44
﹤0.01% 987
2023
Q3
$4.44K Hold
44
﹤0.01% 989
2023
Q2
$5.98K Hold
44
﹤0.01% 952
2023
Q1
$4.57K Buy
+44
New +$4.25K ﹤0.01% 995
2022
Q4
Sell
-44
Closed -$4K 301
2022
Q3
$4K Hold
44
﹤0.01% 919
2022
Q2
$4K Hold
44
﹤0.01% 912
2022
Q1
$7K Buy
44
+22
+100% +$3.07K ﹤0.01% 787
2021
Q4
$3K Hold
22
﹤0.01% 934
2021
Q3
$3K Hold
22
﹤0.01% 898
2021
Q2
$3K Hold
22
﹤0.01% 918
2021
Q1
$2K Buy
+22
New +$2.65K ﹤0.01% 852

Other funds holding CNMD

GPS Wealth Strategies Group's CNMD Position: Q2 2024 in Review

GPS Wealth Strategies Group sold out of CONMED (CNMD) in Q2 2024, closing a stake of 44 shares — an estimated $3.52K sold.

GPS Wealth Strategies Group first reported a position in CNMD in Q1 2021 and held it in 12 quarters. The position peaked at $7K in Q1 2022. 290 funds tracked by Wall St. Rank hold CNMD as of Q2 2024.

  • GPS Wealth Strategies Group reported no remaining CONMED position as of Q2 2024 after selling out during the quarter.
  • GPS Wealth Strategies Group sold 44 CONMED shares in Q2 2024, an estimated $3.52K.
  • GPS Wealth Strategies Group first reported a position in CONMED in Q1 2021 and held it in 12 quarters.
  • GPS Wealth Strategies Group's CONMED position peaked at $7K in Q1 2022.
  • 290 funds tracked by Wall St. Rank held CONMED as of Q2 2024.

Based on GPS Wealth Strategies Group's 13F filing for Q2 2024, filed 16 Jul 2024.